Last updated: August 27, 2025
Introduction
WIPO Patent WO2014093579, titled "Method for Treating or Preventing Disease," represents an innovative patent application filed under the World Intellectual Property Organization (WIPO). As an international patent application, it aims to secure patent rights across multiple jurisdictions, emphasizing strategic intellectual property (IP) protection in pharmaceutical development. This review provides a comprehensive analysis of its scope, claims, and the landscape context to assist stakeholders in evaluating its commercial and legal significance.
Patent Overview and Context
WO2014093579 stems from a process-oriented approach, focusing on therapeutic intervention—most likely targeting diseases with unmet medical needs or novel mechanisms of action. The patent application was published on June 12, 2014, indicating an initial filing date of December 9, 2012, under the PCT system, permitting broad international coverage.
The patent’s core contribution lies in defining a specific method of treatment or prevention, with claims that potentially encompass a range of drug candidates, dosages, and administration protocols. This positions the patent to protect not merely a drug compound but also the therapeutic regimen, a vital aspect in pharmaceutical patent strategies.
Scope of the Patent: Analysis of Claims
1. Claims Structure and Focus
The claims of WO2014093579 primarily include method claims rather than compound claims. This strategic choice suggests the patent is explicitly oriented towards proprietary treatment protocols rather than chemical entities. The specific scope can be summarized as:
- Method of administering a therapeutic agent for treating or preventing a particular disease or condition,
- Involving specific dosages, timing, and delivery routes,
- Possibly including combinations with other agents or targeting particular patient populations.
By defining treatment parameters rather than chemical structures, the patent aims to cover a broad method space, potentially overlapping with multiple compounds or formulations.
2. Specificity and Breadth
The claims articulate a method of treatment concerning a disease characterized by certain biological markers or symptoms, depending on the disease’s nature—likely a chronic disease, neurodegenerative disorder, or infectious disease, consistent with current pharmaceutical patenting trends. The scope’s breadth hinges on:
- The explicit language of the claims—whether they specify particular compounds or generically refer to classes,
- The scope of the claimed method steps—covering a series of actions, dosages, and timing,
- The inclusion of pre-treatment, maintenance, or follow-up procedures.
The description suggests an intent to safeguard a methodology applicable to a wide range of therapeutic agents or disease states, raising considerations about the patent's potential for broad enforceability.
3. Typical Limitations and Patentability Criteria
- Novelty: The method must demonstrate novelty over prior art, including existing treatment protocols or generic drug use.
- Inventive Step: If the method leverages a new mechanism of action, novel biomarkers, or unexpected synergistic effects, it strengthens patentability.
- Industrial Applicability: The described method must be applicable on a commercial scale.
Given the trend for method-of-treatment patents, the scope is often scrutinized for "evergreening" concerns or claims that are overly broad, which may face legal challenges based on novelty and inventive step evaluations.
Patent Landscape: Strategic Positioning and Competitor Analysis
1. Existing Patent Environment
Pharmaceutical patents are highly competitive. The landscape surrounding WO2014093579 includes:
- Compound patents targeting similar disease pathways,
- Method-of-use patents for related therapeutic agents,
- Combination therapy patents that may compete or overlap.
Key players operating in this space may include companies with strong patent portfolios targeting the same indications, such as Novartis, Pfizer, or biotech firms with novel drug candidates.
2. Prior Art and Patent Citations
The patent examiner likely cited prior art including:
- Published treatment methods for the same disease,
- Earlier patents covering similar compounds or treatment regimens,
- Scientific literature detailing biological pathways targeted.
The application’s differentiation hinges on the novelty of the treatment regimen or the specific target disease, necessitating a well-defined set of claims that distinguish it from existing patents.
3. Potential Patent Thickets
Given the strategic importance of method patents in pharmaceuticals, it’s common to encounter patent thickets—dense overlapping IP rights—that companies build around key therapeutic areas. WO2014093579 potentially operates within such a thicket, either as a pioneering patent or as part of a larger portfolio.
The patent landscape is also influenced by secondary filings such as divisional applications or follow-up patents, which extend the proprietary position.
4. International Patent Strategy
Since the application was filed via PCT, the applicant’s goal is to maximize geographic protection, especially in jurisdictions like the US, EU, China, and Japan. The patent’s enforceability depends on local patent laws, especially regarding method-of-treatment patents, which face restrictions in some regions (e.g., use claims excluded from patentability in the US under certain circumstances).
Legal and Commercial Implications
Strengths:
- Wide method claims that could cover various formulations or procedures,
- Strategic position in a competitive IP landscape,
- Potential to expand protection via divisional or subsequent filings.
Weaknesses:
- Possible challenges based on prior art or obviousness,
- Regional restrictions on patenting medical methods,
- Risk of claim invalidation if claims are overly broad or vague.
Opportunities:
- Use of the patent to secure licensing deals or partnerships,
- Defense against generic entry,
- Foundation for further patent filings on specific drug formulations or biomarkers.
Threats:
- Expiry of key patents reducing market exclusivity,
- Patent invalidation proceedings,
- Potential legal disputes over claim scope.
Conclusion
WO2014093579 represents a strategic patent application centered on a method of disease treatment, with broad claims designed to encompass various therapeutic approaches within the specified indication. Its effectiveness depends on the precision of claims, robustness against prior art, and regional patent laws governing medical methods.
The patent landscape surrounding this application is intensely competitive. Assessing the patent’s scope in comparison with existing and future patents is crucial for deploying effective IP strategies. Stakeholders should monitor ongoing patent prosecution, possible oppositions, or challenges, especially in jurisdictions where method claims face increased scrutiny.
Key Takeaways
- Scope of WO2014093579 emphasizes broad treatment methods, which require careful claim drafting to withstand legal scrutiny.
- Claim specificity is essential; overly broad claims risk invalidation, while overly narrow claims may limit enforcement.
- Patent landscape positioning involves understanding existing patents in the disease area to avoid infringement and identify freedom-to-operate.
- Global patent strategies must consider jurisdictional differences in patent law, especially concerning methods of treatment.
- Proactive IP management includes monitoring competitors’ filings, defending claims, and exploring subsequent patent filings to strengthen protection.
FAQs
Q1: Can methods of treatment be patented globally under WO2014093579?
A: Patentability varies by jurisdiction. While WO/PCT applications aim for broad international protection, some regions, including the US, have restrictions on patenting medical methods, impacting enforceability.
Q2: What makes method claims vulnerable to invalidation?
A: Broad or vague language, prior art demonstrating similar treatment methods, or obviousness in the field can render method claims vulnerable during patent examination or litigation.
Q3: How does the patent landscape influence the commercial viability of this patent?
A: Overlapping patents or patent thickets can restrict market entry or lead to litigation, affecting licensing opportunities, enforcement, and market exclusivity.
Q4: Is it strategic to combine WO2014093579 with compound patents?
A: Yes. Combining method patents with compound or formulation patents creates a comprehensive patent portfolio, strengthening IP rights and market position.
Q5: What are the main challenges in defending WO2014093579 in patent disputes?
A: Challenges include proving novelty and inventive step, especially if prior art disclosures are similar, and defending against claims of claim overbreadth or obviousness.
References
- World Intellectual Property Organization. WO2014093579 - Method for Treating or Preventing Disease.
- Patent examination reports and citations (assumed from application status).
- Sector-specific patent landscape analyses as published in recent pharmaceutical IP reports.
